Tackling high-burden for patients and under-researched medical conditions

Opened

Programme Category

EU Competitive Programmes

Programme Name

Horizon Europe (2021-2027)

Programme Description

Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.

Programme Details

Identifier Code

HORIZON-HLTH-2025-01-DISEASE-07

Call

Tackling high-burden for patients and under-researched medical conditions

Summary

A number of medical conditions fail to be recognised and/or be correctly diagnosed in a significant proportion of patients.

As a consequence, they are inadequately treated and often can become a chronic and high burden for the patient.

These medical conditions, including:

  1. myalgic encephalomyelitis/chronic fatigue syndrome,
  2. autism,
  3. gynaecological diseases,
  4. low back pain,
  5. other,

may be insufficiently researched even though they manifest with high prevalence.

Detailed Call Description

Research actions under this topic should include all the following activities, ensuring multidisciplinary approaches and a broad representation of stakeholders in the consortia:

  • Proposals should address the gaps in robust, scientific evidence for improved policies and practices to tackle such a medical condition and aim at identifying the pathophysiological mechanism(s) (e.g. genetic, cellular and molecular) and potential risk factors (e.g. psychological and environmental) of the medical condition through basic, pre-clinical and/or clinical research. These efforts should underpin the development of diagnostics, therapeutics, and/or preventive strategies for the condition.
  • Proposals should demonstrate that the medical condition under study is insufficiently understood, inaccurately diagnosed or inadequately treated in a significant proportion of patients, and as such represent a high burden for patients and society. This could be through referencing key literature.
  • Sex and gender-related aspects, age, ethnicity, socio-economic, lifestyle and behavioural factors should be taken into consideration. In addition, the emotional and societal long-term effects of these chronic disorders for the affected individuals should be addressed.
  • Where applicable, the development of biomarkers and other technologies for diagnosis, monitoring in patients, and stratification of patient groups should be considered.
  • Where applicable, the development of clinically relevant, (non-)human model systems that can complement clinical investigations should be considered.
  • Exploitation of existing data, biobanks, registries and cohorts is expected, together with the generation of new (e.g. genomics, epigenomics, transcriptomics, proteomics) data.
  • To enable sharing of samples, quality data and advanced analytical tools, it is encouraged to make use of existing infrastructures developed at the European or national level.
  • Inclusion of patients or patient organisations in the research is strongly encouraged, to ensure that their views are considered.
  • Participation of startups and small and medium-sized enterprises (SMEs) is strongly encouraged.

This topic requires the effective contribution of social sciences and humanities (SSH) disciplines and the involvement of SSH experts, institutions as well as the inclusion of relevant SSH expertise, in order to produce meaningful and significant effects enhancing the societal impact of the related research activities.

Call Total Budget

€30.00 million

Financing percentage by EU or other bodies / Level of Subsidy or Loan

100%

Expected EU contribution per project: €6.00 million.

Thematic Categories

  • Health
  • Other Services
  • Research, Technological Development and Innovation
  • Social Affairs & Human Rights

Eligibility for Participation

  • Legal Entities
  • NGOs
  • Non Profit Organisations
  • Other Beneficiaries
  • Private Bodies
  • Researchers/Research Centers/Institutions

Eligibility For Participation Notes

In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.

If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).

A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects.

Call Opening Date

22/05/2025

Call Closing Date

16/09/2025

National Contact Point(s)

Research and Innovation Foundation

29a Andrea Michalakopoulou, 1075 Nicosia,
P.B. 23422, 1683 Nicosia
Telephone: +357 22205000
Fax: +357 22205001
Email: support@research.org.cy
Websitehttps://www.research.org.cy/en/

Contact Person:
George Christou
Scientific Officer
Email: gchristou@research.org.cy